The European Patient Advocacy Institute (EPAI), established as a non-profit organisation in Germany in 2017, acts as an education and research platform to strengthen patient advocacy and patient involvement.
EPAI leads and guides the development and implementation of methodologies, processes, and projects to strengthen patient advocacy, patient involvement and evidence generation in research, health policy and healthcare services.
EPAI works closely with the Workgroup of European Patient Advocacy Networks (WECAN) and bases its activities on the tools and frameworks built e.g. by WECAN, Patient Focused Medicines Development (PFMD) and the European Patients’ Academy (EUPATI).
Statutes & Objectives
Development and implementation of educational measures in the field of medical research and development in various formats, in particular for medical laypersons such as patients, relatives, nursing staff and for local, regional, national and international patient organizations.
Clarification, education and the provision of practical knowledge in the field of medicine, locally, regionally, nationally and internationally, making a contribution to constant and sustainable medical research and development, the best and informed use of public health services, as well as consumer advice and consumer protection